StonvexLoading…
StonvexCore line items from FSLY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $624.02M | $543.68M | $505.99M | $432.73M |
Operating Income | $-119.00M | $-167.91M | $-198.03M | $-246.20M |
Net Income | $-121.68M | $-158.06M | $-133.09M | $-190.77M |
EPS (Diluted) | $-0.83 | $-1.14 | $-1.03 | $-1.57 |
Total Assets | $1.50B | $1.45B | $1.53B | $1.90B |
Total Liabilities | $569.90M | $486.11M | $545.70M | $940.96M |
Cash & Equivalents | $180.56M | $286.18M | $107.92M | $143.39M |
Free Cash Flow OCF − CapEx | $65.75M | $6.08M | $-10.61M | $-89.61M |
Shares Outstanding | 146.90M | 142.09M | 132.99M | 124.34M |